Monsenso AS
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more
Monsenso AS (MONSO) - Net Assets
Latest net assets as of December 2025: Dkr6.98 Million DKK
Based on the latest financial reports, Monsenso AS (MONSO) has net assets worth Dkr6.98 Million DKK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr13.05 Million) and total liabilities (Dkr6.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr6.98 Million |
| % of Total Assets | 53.46% |
| Annual Growth Rate | 1.84% |
| 5-Year Change | -67.47% |
| 10-Year Change | 7.24% |
| Growth Volatility | 120.39 |
Monsenso AS - Net Assets Trend (2015–2025)
This chart illustrates how Monsenso AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Monsenso AS (2015–2025)
The table below shows the annual net assets of Monsenso AS from 2015 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr6.98 Million | -50.75% |
| 2024-12-31 | Dkr14.16 Million | +30.27% |
| 2023-12-31 | Dkr10.87 Million | -26.31% |
| 2022-12-31 | Dkr14.76 Million | -31.19% |
| 2021-12-31 | Dkr21.44 Million | +14.95% |
| 2020-12-31 | Dkr18.65 Million | +382.76% |
| 2019-12-31 | Dkr3.86 Million | +1.23% |
| 2018-12-31 | Dkr3.82 Million | -22.18% |
| 2017-12-31 | Dkr4.91 Million | -24.60% |
| 2016-12-31 | Dkr6.51 Million | +11.96% |
| 2015-12-31 | Dkr5.81 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Monsenso AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 95061700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Dkr242.00K | 3.47% |
| Common Stock | Dkr6.68 Million | 95.71% |
| Other Comprehensive Income | Dkr57.00K | 0.82% |
| Total Equity | Dkr6.98 Million | 100.00% |
Monsenso AS Competitors by Market Cap
The table below lists competitors of Monsenso AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CENTURION FIN.A-C ZY -10
F:6F4
|
$904.43K |
|
Atlas Metals Group plc
F:D0Z
|
$905.08K |
|
RBG HOLDINGS PLC LS-002
F:9WN
|
$905.56K |
|
DOVRE GROUP OYJ
F:0BE
|
$905.66K |
|
Visium Technologies Inc
PINK:VISM
|
$903.82K |
|
Lavide Holding NV
AS:LVIDE
|
$903.58K |
|
Miwon Commercial Co. Ltd.
KQ:002840
|
$903.58K |
|
TRADEGATE
BE:T2G
|
$903.43K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Monsenso AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,164,000 to 6,976,000, a change of -7,188,000 (-50.7%).
- Net loss of 7,217,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr-7.22 Million | -103.45% |
| Other Changes | Dkr29.00K | +0.42% |
| Total Change | Dkr- | -50.75% |
Book Value vs Market Value Analysis
This analysis compares Monsenso AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.05x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.02x to 1.05x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | Dkr6.71 | Dkr0.11 | x |
| 2016-12-31 | Dkr7.53 | Dkr0.11 | x |
| 2017-12-31 | Dkr1.43 | Dkr0.11 | x |
| 2018-12-31 | Dkr1.12 | Dkr0.11 | x |
| 2019-12-31 | Dkr0.34 | Dkr0.11 | x |
| 2020-12-31 | Dkr1.16 | Dkr0.11 | x |
| 2021-12-31 | Dkr0.87 | Dkr0.11 | x |
| 2022-12-31 | Dkr0.54 | Dkr0.11 | x |
| 2023-12-31 | Dkr0.39 | Dkr0.11 | x |
| 2024-12-31 | Dkr0.28 | Dkr0.11 | x |
| 2025-12-31 | Dkr0.10 | Dkr0.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Monsenso AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -103.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -81.03%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.87x
- Recent ROE (-103.45%) is below the historical average (-45.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -21.58% | -91.42% | 0.13x | 1.87x | Dkr-1.74 Million |
| 2016 | -43.14% | -50.73% | 0.49x | 1.74x | Dkr-3.28 Million |
| 2017 | -68.52% | -52.33% | 0.40x | 3.29x | Dkr-3.85 Million |
| 2018 | -54.68% | -27.82% | 0.57x | 3.46x | Dkr-2.47 Million |
| 2019 | 0.62% | 0.27% | 0.77x | 2.97x | Dkr-362.40K |
| 2020 | -25.27% | -52.00% | 0.32x | 1.53x | Dkr-6.58 Million |
| 2021 | -38.02% | -114.14% | 0.26x | 1.26x | Dkr-10.30 Million |
| 2022 | -53.23% | -126.41% | 0.33x | 1.28x | Dkr-9.33 Million |
| 2023 | -49.27% | -55.66% | 0.51x | 1.74x | Dkr-6.44 Million |
| 2024 | -42.37% | -53.75% | 0.60x | 1.31x | Dkr-7.42 Million |
| 2025 | -103.45% | -81.03% | 0.68x | 1.87x | Dkr-7.91 Million |
Industry Comparison
This section compares Monsenso AS's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $6,470,079
- Average return on equity (ROE) among peers: -6.92%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Monsenso AS (MONSO) | Dkr6.98 Million | -21.58% | 0.87x | $903.95K |
| Brain+ ApS (BRAINP) | $6.47 Million | -6.92% | 0.41x | $968.01 |